MADRID, 10 Nov. (EUROPA PRESS) –
The Spanish startup Sherpa.ai has signed an agreement with the National Institutes of Health (NIH), dependent on the United States Department of Health, to improve its diagnosis and treatment of rare diseases through the applied artificial intelligence platform of the Spanish.
The company will thus provide the world’s largest biomedical research agency with its specialized platform for analyzing data while preserving privacy for the analysis of millions of patients, according to a statement.
The Sherpa.ai Federated Learning platform will allow the NIH to train its algorithms with data from different sources in a secure way and without sharing the received data.
NIH senior researcher Carsten G. Bönnemann has stressed that the Sherpa.ai platform could make it possible to explore new diagnostic and treatment possibilities for a group of diseases that currently have no specific treatment.
The results of the joint work will be made public in the coming months, although the founder of Sherpa.ai, Xabi Uribe-Extebarria, has stressed that the first results “are very encouraging.”
